Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study
- PMID: 28967230
- PMCID: PMC7379992
- DOI: 10.1111/luts.12193
Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study
Abstract
Objective: The aim of the present study was to determine the prevalence of overactive bladder (OAB) in individuals aged ≥40 years in China, Taiwan, and South Korea.
Methods: The present cross-sectional population-representative Internet-based study investigated OAB symptoms in men and women aged ≥40 years using the overactive bladder symptom score. Additional instruments included the International Index of Erectile Function (men only) and the Sexual Quality of Life - Female (women only) questionnaires, as well as Patient Perception of Bladder Condition (PPBC).
Results: In all, 8284 individuals participated in the study. The prevalence of OAB was 20.8% overall (women 22.1%, men 19.5%) and increased significantly with age, from 10.8% in those aged 40-44 years to 27.9% in those aged >60 years (P = .001). The presence of comorbid conditions (e.g. neurological disease, diabetes) was associated with a significantly increased prevalence of OAB. Increasing symptom severity was associated with significantly worsening patient perception of bladder condition responses. Just under half (48%) of those with no OAB had no lower urinary tract symptoms (LUTS), whereas 88% of those with severe symptoms had all 3 LUTS (International Continence Society definition) symptom categories (voiding, post-micturition, and storage symptoms). Of those without OAB, 10% reported visiting healthcare professionals for urinary symptoms, compared with 64% of those with severe OAB symptoms (P = .001). Increased symptom severity was significantly associated with lower sexual quality of life in both men and women.
Conclusions: OAB symptoms were found to affect 1 in 5 individuals aged ≥40 years in China, Taiwan, and South Korea, becoming more common with increasing age. The results suggest that many more individuals with OAB could benefit by consulting healthcare professionals.
Keywords: China; Republic of Korea; Taiwan; overactive bladder; prevalence.
© 2017 The Authors. LUTS Published by John Wiley & Sons Australia, Ltd.
Figures


Similar articles
-
The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study.World J Urol. 2018 Nov;36(11):1853-1862. doi: 10.1007/s00345-018-2329-0. Epub 2018 May 23. World J Urol. 2018. PMID: 29796775
-
Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.BMC Urol. 2017 Nov 21;17(1):108. doi: 10.1186/s12894-017-0294-3. BMC Urol. 2017. PMID: 29162085 Free PMC article.
-
Prevalence of Lower Urinary Tract Symptoms in China, Taiwan, and South Korea: Results from a Cross-Sectional, Population-Based Study.Adv Ther. 2017 Aug;34(8):1953-1965. doi: 10.1007/s12325-017-0577-9. Epub 2017 Jul 7. Adv Ther. 2017. PMID: 28687936 Free PMC article.
-
Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.Curr Urol Rep. 2018 Sep 13;19(11):94. doi: 10.1007/s11934-018-0839-3. Curr Urol Rep. 2018. PMID: 30215140 Review.
-
Overactive bladder in Taiwanese women: re-analysis of epidemiological database of community from 1999 to 2001.Neurourol Urodyn. 2012 Jan;31(1):56-9. doi: 10.1002/nau.21190. Epub 2011 Aug 8. Neurourol Urodyn. 2012. PMID: 21826728 Review.
Cited by
-
A Dataset for Constructing the Network Pharmacology of Overactive Bladder and Its Application to Reveal the Potential Therapeutic Targets of Rhynchophylline.Pharmaceuticals (Basel). 2024 Sep 24;17(10):1253. doi: 10.3390/ph17101253. Pharmaceuticals (Basel). 2024. PMID: 39458894 Free PMC article.
-
Comprehensive analysis of global research on overactive bladder: A scientometric approach.Front Surg. 2023 Jan 6;9:1078052. doi: 10.3389/fsurg.2022.1078052. eCollection 2022. Front Surg. 2023. PMID: 36684181 Free PMC article.
-
Effects and safety of herbal medicines on patients with overactive bladder: A protocol for a systematic view and meta-analysis.Medicine (Baltimore). 2019 Sep;98(37):e17005. doi: 10.1097/MD.0000000000017005. Medicine (Baltimore). 2019. PMID: 31517818 Free PMC article.
-
Pooled analysis of the efficacy and safety of tibial nerve stimulation versus antimuscarinic agents in the management of overactive bladder syndrome.Medicine (Baltimore). 2021 Nov 12;100(45):e27745. doi: 10.1097/MD.0000000000027745. Medicine (Baltimore). 2021. PMID: 34766587 Free PMC article.
-
Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction.Toxins (Basel). 2018 Jun 26;10(7):260. doi: 10.3390/toxins10070260. Toxins (Basel). 2018. PMID: 29949878 Free PMC article. Review.
References
-
- Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological Association, Society of Urodynamics, Female Pelvic Medicine . Diagnosis and treatment of overactive bladder (non‐neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193:1572–1580. - PubMed
-
- Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104:352–360. - PubMed
-
- Coyne KS, Sexton CC, Weinstein D, et al. The prevalence of OAB in the US, UK and Sweden: results from EpiLUTS. J Urol. 2009;181 (Suppl):160.
-
- Irwin DE, Milsom I, Hunskaar S, et al. Population‐based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–1314. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical